| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.44B+11.9% | $1.29B+16.0% | $1.11B+22.5% | $905.2M+29.5% | $699.0M+39.2% | $502.0M+30.8% | $383.9M+26.3% | $304.0M |
| Veterinary invoice expense | $1.03B+8.4% | $949.1M+14.2% | $831.1M+27.9% | $649.7M+33.7% | $486.1M+38.4% | $351.1M+29.6% | $270.9M+26.3% | $214.5M |
| Other cost of revenue | $179.3M+13.7% | $157.7M+7.6% | $146.5M+10.0% | $133.3M+22.7% | $108.6M+57.4% | $69.0M+43.6% | $48.1M+26.3% | $38.1M |
| Total cost of revenue | $1.21B+9.2% | $1.11B+13.2% | $977.6M+24.9% | $783.0M+31.7% | $594.6M+41.5% | $420.1M+31.7% | $319.0M+26.3% | $252.6M |
| Technology and development | $37.8M+21.1% | $31.3M+46.0% | $21.4M-14.8% | $25.1M+49.0% | $16.9M+69.6% | $9.9M+41.6% | $7.0M+21.2% | $5.8M |
| General and administrative | $76.6M+20.3% | $63.7M+5.9% | $60.2M+52.9% | $39.4M+23.5% | $31.9M+46.0% | $21.8M+18.8% | $18.4M+7.5% | $17.1M |
| New pet acquisition expense | $85.4M+19.7% | $71.4M-7.7% | $77.4M-13.6% | $89.5M+13.8% | $78.6M+64.4% | $47.8M+34.9% | $35.5M+41.8% | $25.0M |
| Goodwill, Impairment Loss | $1.1M-78.7% | $5.3M | $0 | $0 | — | — | — | — |
| Depreciation and amortization | $15.8M-3.8% | $16.5M+32.0% | $12.5M+14.2% | $10.9M-8.7% | $12.0M+69.2% | $7.1M+25.6% | $5.6M+24.8% | $4.5M |
| Total operating expenses | $216.9M+15.3% | $188.1M+9.7% | $171.5M+4.0% | $164.9M+18.3% | $139.4M+60.7% | $86.7M+30.4% | $66.5M+26.9% | $52.4M |
| Loss from investment in joint venture | -$305K-67.6% | -$182K+16.9% | -$219K+13.4% | -$253K-48.0% | -$171K-35.7% | -$126K+64.2% | -$352K | $0 |
| Operating income (loss) | $13.8M+245.4% | -$9.5M+76.6% | -$40.7M+5.4% | -$43.0M-22.2% | -$35.2M-614.3% | -$4.9M-156.6% | -$1.9M-83.7% | -$1.0M |
| Interest expense | $13.8M-5.1% | $14.5M+20.0% | $12.1M+183.0% | $4.3M+42570.0% | $10K-99.3% | $1.4M+2.4% | $1.3M+12.6% | $1.2M |
| Other (income), net | -$21.9M-52.5% | -$14.4M-86.7% | -$7.7M-150.7% | -$3.1M-22042.9% | $14K+102.4% | -$581K+64.3% | -$1.6M-24.4% | -$1.3M |
| Income (loss) before income taxes | $22.0M+328.2% | -$9.6M+78.6% | -$45.0M-1.9% | -$44.2M-25.5% | -$35.2M-515.0% | -$5.7M-249.2% | -$1.6M-75.6% | -$934K |
| Income tax expense (benefit) | $2.6M+51320.0% | -$5K+98.5% | -$342K-171.8% | $476K+53.5% | $310K+174.3% | $113K-33.1% | $169K+2514.3% | -$7K |
| Net income (loss) | $19.4M+301.7% | -$9.6M+78.4% | -$44.7M-0.0% | -$44.7M-25.7% | -$35.5M-508.4% | -$5.8M-222.8% | -$1.8M-95.1% | -$927K |
| Earnings Per Share, Basic | $0.45+295.7% | -$0.23+78.7% | -$1.08+1.8% | -$1.10+99.9% | -$890.00-456.3% | -$160.00 | — | — |
| Earnings Per Share, Diluted | $0.45+295.7% | -$0.23+78.7% | -$1.08+1.8% | -$1.10+99.9% | -$890.00-456.3% | -$160.00 | — | — |
| Weighted Average Number of Shares Outstanding, Basic | 43.0M+1.9% | 42.2M+1.7% | 41.4M+1.6% | 40.8M-99.9% | 40.14B+11.9% | 35.86B | — | — |
| Weighted Average Number of Shares Outstanding, Diluted | 43.6M+3.3% | 42.2M+1.7% | 41.4M+1.6% | 40.8M-99.9% | 40.14B+11.9% | 35.86B | — | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.